Is COP.DE stock a buy after the recent bounce?

COP.DE stock can be a tactical buy for short-term traders if volume confirms the move. Use a tight stop below **€20.00**. For longer-term investors, weigh high leverage (net-debt/EBITDA **5.01**) and mixed earnings growth before increasing exposure.

What are realistic price targets for COP.DE stock?

Meyka AI projects a base target **€25.00** (+**10.33%**), a bull scenario **€28.00** (+**23.58%**) and a bear scenario **€19.00** (-**16.15%**) versus the current **€22.66**. These are model projections and not guarantees.

Which risks should traders watch for COP.DE stock?

Key risks for COP.DE stock include high net debt (net-debt/EBITDA **5.01**), slowing EPS growth, and sector spending headwinds. Watch earnings updates, cash flow trends, and any material M&A news for changes to the trade thesis.

DE Stocks

COP.DE CompuGroup Medical (XETRA) €22.66 on 24 Mar 2026: Oversold bounce entry

ByDanny Kontos March 25, 2026March 25, 2026

COP.DE stock closed at €22.66 on 24 Mar 2026 on XETRA in Germany, setting up a classic oversold bounce trade as volume surged to 145,385 shares. The share price sits just above its 50-day average (€22.14) and well above the 200-day average (€19.90), giving traders a technical foothold. Short-term momentum favors buyers after a large relative volume spike (rel. vol 3.02) and a move back from the intraday low of €22.28. We examine valuation, technical triggers, risks and a trade plan framed by Meyka AI’s analysis and a conservative price forecast.